MENU
MTSR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Metsera (MTSR) Earnings Date & Reports

Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions... Show more

A.I. Advisor
published Earnings

MTSR is expected to report earnings to rise 22.73% to -81 cents per share on December 03

Metsera MTSR Stock Earnings Reports
Q3'25
Est.
$-0.81
Q2'25
Missed
by $0.03
The last earnings report on July 28 showed earnings per share of -66 cents, missing the estimate of -62 cents. With 1.51M shares outstanding, the current market capitalization sits at 3.77B.
View a ticker or compare two or three
MTSR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MTSR showed earnings on July 28, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details